Penny,
The standard of care guidelines are starting to become more and more complex. You can have this treatment as first line, that treatment as 2nd line. I'm disappointed to that you couldn't receive it. I wish approvals could be more broad.
@Lani, after 4300 posts we just take you for granted.
The Perjeta for neoadjuvant treatment is big news and shows an enormous shift in standards (pCR). We share your enthusiasm and note that you were the first to scoop the story.